Third day result. Buy n sell. Keep green. Always have a trading plan. Set clear goals. Define your risk tolerance and outline your entry and exit strategies before placing any trad
Earnings reports from$Disney (DIS.US)$,$Airbnb (ABNB.US)$,$Hilton Worldwide (HLT.US)$, and energy drink giant$Monster Beverage (MNST.US)$all warn that U.S. consumer spending is "definitely weakening." Due to rising prices and shrinking savings, Americans are cutting back on spending in areas such as dining and travel and becoming more cautious. Major U.S. cons...
Alrighty, folks, grab your bevvies and sit tight because Monster Beverage just pulled a massive faceplant in the stock market! I’m talking a 10% dive after hours on Wednesday. So, here’s the deal: Monster thought they were the king of the energy drinks, but they only brought in $1.9 billion in Q2. Now, $1.9 billion sounds like a big ol' chunk of change, right? But the analysts—those cheeky buggers—were expecting $2.01 billio...
Good morning, traders. Happy Thursday, the market is trying to climb up after falling back. The Nasdaq and tech stocks were still in correction territory from their heights in the lush days of July. My name is Kevin Travers, here are moovin' stonks. Eli Lilly$Eli Lilly and Co (LLY.US)$posted a Q2 earnings beat, boosted by demand for the company's Mounjaro diabetes treatment and weight-loss drug Zepbound. The stock climbed 8%, and ...
$Monster Beverage (MNST.US)$further proof consumers aren't spending two and a half three bucks for a can of monster. if they can't afford McDonald's if they can't afford Burger King oh they missed two qsr parent company Papa Gino's missed the writing's on the wall plane is day. consumers are not spending we are not consuming at the rate that we used to
Morning Movers Gapping up $Eli Lilly and Co (LLY.US)$'s stock increased by 11.5% after the pharmaceutical company boosted its annual profit forecast, with sales of its weight-loss drug Zepbound surpassing the $1 billion mark in a single quarter for the first time. $Apple (AAPL.US)$'s stock edged up by 0.1% following a report from CNBC that the tech giant may introduce a charge of up to $20 for advanced artificial intelligence f...
$Monster Beverage (MNST.US)$sank nearly 10% after hours Wednesday after the energy-drink giant missed analyst expectations for its Q2 revenues and earnings. MNST fell 9% to $46 shortly before 4:45 p.m. ET after reporting $1.9 billion of Q2 net sales, rising from $1.85 billion in the same period last year, but missing the $2.01 billion consensus that analysts had reportedly expected. Diluted earnings per share came in at...
Investors are pulling out of tech stocks and shifting to lagging sectors, but the consumer goods industry hasn't reaped much benefit. As of July 31, the Nasdaq Index has fallen 5.7% after hitting a record high of 18,671 points on July 11. Meanwhile, the S&P 500 Consumer Select Sector Index remained nearly flat, the S&P Biotechnology Select Industry Index rose 3.7%, and the$Russell 2000 Index (.RUT.US)$gained 10.7...
Monster Beverage Stock Forum
Always have a trading plan. Set clear goals. Define your risk tolerance and outline your entry and exit strategies before placing any trad
So, here’s the deal: Monster thought they were the king of the energy drinks, but they only brought in $1.9 billion in Q2. Now, $1.9 billion sounds like a big ol' chunk of change, right? But the analysts—those cheeky buggers—were expecting $2.01 billio...
Eli Lilly $Eli Lilly and Co (LLY.US)$ posted a Q2 earnings beat, boosted by demand for the company's Mounjaro diabetes treatment and weight-loss drug Zepbound. The stock climbed 8%, and ...
consumers are not spending we are not consuming at the rate that we used to
Gapping up
$Eli Lilly and Co (LLY.US)$ 's stock increased by 11.5% after the pharmaceutical company boosted its annual profit forecast, with sales of its weight-loss drug Zepbound surpassing the $1 billion mark in a single quarter for the first time.
$Apple (AAPL.US)$ 's stock edged up by 0.1% following a report from CNBC that the tech giant may introduce a charge of up to $20 for advanced artificial intelligence f...
MNST fell 9% to $46 shortly before 4:45 p.m. ET after reporting $1.9 billion of Q2 net sales, rising from $1.85 billion in the same period last year, but missing the $2.01 billion consensus that analysts had reportedly expected.
Diluted earnings per share came in at...
As of July 31, the Nasdaq Index has fallen 5.7% after hitting a record high of 18,671 points on July 11. Meanwhile, the S&P 500 Consumer Select Sector Index remained nearly flat, the S&P Biotechnology Select Industry Index rose 3.7%, and the $Russell 2000 Index (.RUT.US)$ gained 10.7...
No comment yet